title: Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis.
abstract: OBJECTIVE
  To describe the process underpinning the development of clinical guidelines for the management of behavioural disturbance in psychosis.
  
  
  METHODS
  A structured process was followed, encompassing a literature review, focus groups with key staff, and pilot testing and monitoring of the guidelines in an acute psychiatric setting.
  
  
  RESULTS
  The process was well accepted by staff and was found useful in monitoring outcomes in a naturalistic setting. The final guidelines proved safe and effective in the acute setting.
  
  
  CONCLUSIONS
  The incorporation of a monitoring system for interventions for the management of behavioural disturbance in acute psychiatric settings is beneficial for staff and patients alike.
authors.affiliation: Mental Health Research Institute, University of Melbourne, Parkville, Vic., Australia. dcastle@mhri.edu.au
authors.forename: David
authors.initials: D
authors.lastname: Castle
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Daniel
authors.forename: Jonathan
authors.initials: J
authors.lastname: Knott
authors.forename: John
authors.initials: J
authors.lastname: Fielding
authors.forename: Joyce
authors.initials: J
authors.lastname: Goh
authors.forename: Bruce
authors.initials: B
authors.lastname: Singh
mesh_terms: D000208:Acute Disease; D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D004358:Drug Therapy; D017144:Focus Groups; D006801:Humans; D008991:Monitoring, Physiologic; D017410:Practice Guidelines as Topic; D011618:Psychotic Disorders / Q000150:complications / Q000523:psychology*; D012449:Safety; D016896:Treatment Outcome